• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Methsuximide-[d5]

General Information
Catalog: BLP-012667
CAS: 1189980-63-9
Molecular Formula: C12H8D5NO2
Molecular Weight: 208.27
Chemical Structure
Methsuximide-[d5]
Description Methsuximide-[d5] is the labelled analogue of Methsuximide. Methsuximide is a succinimide anticonvulsant drug.
Synonyms Methsuximide-D5; 1,3-Dimethyl-3-(phenyl-d5)-2,5-pyrrolidinedione
IUPAC Name 1,3-dimethyl-3-(2,3,4,5,6-pentadeuteriophenyl)pyrrolidine-2,5-dione
Related CAS 77-41-8 (unlabelled)
Isomeric SMILES [2H]C1=C(C(=C(C(=C1[2H])[2H])C2(CC(=O)N(C2=O)C)C)[2H])[2H]
Canonical SMILES CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2
InChI InChI=1S/C12H13NO2/c1-12(9-6-4-3-5-7-9)8-10(14)13(2)11(12)15/h3-7H,8H2,1-2H3/i3D,4D,5D,6D,7D
InChI Key AJXPJJZHWIXJCJ-DKFMXDSJSA-N
Boiling Point 346.4±31.0 °C at 760 mmHg
Purity 98.9% by HPLC; 99.7% atom D
Density 1.2±0.1 g/cm3
Solubility Soluble in Chloroform, Methanol
Appearance Yellow Oil
Application A labelled calcium channel succinimide antiepileptic drug. Anticonvulsant.
Storage Store at -20°C

Interested in our Service & Products?
Need detailed information?

USA
  • International: 1-631-504-6093
  • US & Canada (Toll free): 1-844-BOC(262)-0123
  • 45-16 Ramsey Road, Shirley, NY 11967, USA
  • Email: info@bocsci.com
  • Fax: 1-631-614-7828
UK
  • 44-20-3286-1088
  • 85 Great Portland Street, London, W1W 7LT
  • Email: info@bocsci.com
Copyright © 2025 BOC Sciences. All Rights Reserved.
0
Inquiry Basket

No data available, please add!

Delete selectedGo to checkout

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x